NEW YORK, November 2, 2017 /PRNewswire/ --
Double 2001 levels, Americansspent over $36 billion on vitamins and nutritional supplements in 2016, contributing to a global dietary supplements market expected to exceed $220 billion by the year 2022 (http://nnw.fm/z8Bh1,
The issuance of the patent will enable Lexaria to accelerate its technology out-licensing activities in several key markets. The irony is that this R&D that originated in the cannabis is now finding use in delivery of NSAIDs, vitamins and even nicotine.
"This wide-ranging patent allowance from the USPTO exceeds our expectations. This vastly expanded intellectual property protection will enable us to aggressively pursue new business opportunities in 2018 such as what could be the world's first nicotine edibles for the smokeless tobacco industry, or enhanced products for NSAID-derived pain management, as well as in the rapidly growing cannabis market," Lexaria CEO Chris Bunka stated in the press release announcing the news (http://nnw.fm/2iPIn ).
About IBBN Over the past 10+ years we have consistently introduced new network brands, each specifically designed to fulfil the unique needs of our growing client base and services. Today, we continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients. Please feel free to visit the Investor Based Brand Network (IBBN) www.InvestorBasedBrandNetwork.com
Corporate Communications Contact: NetworkNewsWire (NNW) New York, New York www.NetworkNewsWire.com +1-212-418-1217 Office Editor@NetworkNewsWire.com Media Contact: FN Media Group, LLC NNW@FinancialNewsMedia.com +1-(954)345-0611
Subscribe to our Free Newsletters!
Drug hypersensitivity is an adverse reaction that occurs due to an interaction between a drug and ...
Stiff joints are a major problem for the elderly, as the joints tend to wear-and-tear with ...
Uterine/Endometrial cancer is the sixth most common cancer in women worldwide. Uterine cancer ...View All